bibliographic entry 7573950 [be/7573950]
https://w3id.org/oc/corpus/be/7573950

is a
content
  • Zinman, B, Wanner, C, Lachin, JM, Fitchett, D, Bluhmki, E, Hantel, S, Mattheus, M, Devins, T, Johansen, OE, Woerle, HJ, Broedl, UC, Inzucchi, SE. EMPA REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015; 373: 2117–2128. PMID: 26378978
references